Key facts

Fact sheet

Latest aide memoire

This data might not be the latest available

Upcoming events

Half-year and Q2 2021 results

Virtual roadshow, Goldman Sachs, Asia/Pacific, Australia [management]

Annual Reports


Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Nick Stone


Kevin O'Neil

Kevin O'Neil

Rare Diseases

Christer Gruvris

BioPharmaceuticals (Cardiovascular, Renal & Metabolism), Finance

Josie Afolabi

BioPharmaceuticals (Respiratory & Immunology)

Tom Waldron

Other medicines, COVID-19

Lauren Swales

Jennifer Kretzmann

Corporate access, retail investors

US general enquiries

  • Shareholder information

    Please find relevant shareholder information and shareholder tools on this page

  • Shareholder FAQs

    Answers to frequently asked shareholder questions

  • Governance

    We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance